Retraction
Hydroxyfasudil Alleviates Demyelination Through the Inhibition of MOG Antibody and Microglia Activation in Cuprizone Mouse Model
Paper Information
Record ID:
23478
Author(s):
Publication Date:
January 17, 2019
Retraction Date:
May 22, 2020
(5.5 years years ago)
Subjects:
Institutions:
- Shanxi Medical University, Taiyuan 030001, China
- The Key Research Laboratory of Benefiting Qi for Acting Blood Circulation Method to Treat Multiple Sclerosis of State Administration of Traditional Chinese Medicine, Shanxi University of Traditional Chinese Medicine, Taiyuan 030024, China
- Institute of Brain Science, Shanxi Datong University, Datong 037009, China
- Institute of Neurology, Huashan Hospital, Institutes of Brain Science and State Key Laboratory of Medical Neurobiology, Fudan University, Shanghai, 200025, China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Elsevier
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (2)
2
Total Citations1
Post-Retraction(50.0%)
0
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
0
Within 1 year
0
After 2+ years
417
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Progress in the Application of Drugs for the Treatment of Multiple Sclerosis
Weipeng Wei, Denglei Ma, Lin Li et al. (4 authors)
Frontiers in Pharmacology
Open Access
Published: Jul 2021
41 citations
41 citations
417 days after retraction
Quick Stats
Total Citations:
2
Years Since Retraction:
5.5 years
Open Access:
Yes
Last Checked:
Jul 24, 2025